If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) was previously published as Current Drug Targets-CNS & Neurological Disorders.

Publisher: Bentham Science Publishers

Related content
Volume 11, Number 5, August 2012

< previous issue | all issues | next issue >

Articles

Favourites:Add to Favourites
Favourites:Add to Favourites

Recent Gains in Clinical Multiple Sclerosis Research
pp. 497-505(9)
Authors: F. Runia, T.; D. van Pelt-Gravesteijn, E.; Q. Hintzen, R.

Favourites:Add to Favourites

Pathology of Multiple Sclerosis
pp. 506-517(12)
Authors: Kipp, Markus; van der Valk, Paul; Amor, Sandra

Favourites:Add to Favourites

Optical Coherence Tomography Detection of Neurodegeneration in Multiple Sclerosis
pp. 518-527(10)
Authors: Lidster, Katie; Baker, David

Favourites:Add to Favourites

Viruses and Multiple Sclerosis
pp. 528-544(17)
Authors: Oskari Virtanen, Jussi; Jacobson, Steve

Favourites:Add to Favourites

Multiple Sclerosis: Risk Factors and their Interactions
pp. 545-555(11)
Authors: Disanto, Giulio; M. Morahan, Julia; V. Ramagopalan, Sreeram

Favourites:Add to Favourites

Mechanisms in the Development of Multiple Sclerosis Lesions: Reconciling Autoimmune and Neurodegenerative Factors
pp. 556-569(14)
Authors: M. van Noort, Johannes; Baker, David; Amor, Sandra

Favourites:Add to Favourites

In Vitro and In Vivo Models of Multiple Sclerosis
pp. 570-588(19)
Authors: J. van der Star, Baukje; Y.S. Vogel, Daphne; Kipp, Markus; Puentes, Fabiola; Baker, David; Amor, Sandra

Favourites:Add to Favourites

Clonal Expansion of Mitochondrial DNA Deletions and the Progression of Multiple Sclerosis
pp. 589-597(9)
Authors: R. Campbell, Graham; J. Mahad, Don

Favourites:Add to Favourites

Endogeneous Remyelination: Findings in Human Studies
pp. 598-609(12)
Authors: Kipp, Markus; Victor, Marion; Martino, Gianvito; J.M. Franklin, Robin

Favourites:Add to Favourites
Favourites:Add to Favourites

Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System
pp. 624-641(18)
Authors: Pryce, Gareth; Baker, David

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more